How do low carbohydrate diets affect weight in the long run, and what does the evidence show in Europe?

Low carbohydrate diets explained: calorie balance, insulin response, metabolic adaptation, long-term weight maintenance, and clinical outcomes.

In this episode, we review research on low-carb diets (including ketogenic approaches) and how doctors interpret long-term weight loss data under EU medical guidance.

You’ll learn:

• How carbohydrate restriction influences insulin and appetite

• Why early weight loss may reflect glycogen and water changes

• Evidence comparing low-carb vs balanced calorie-restricted diets

• The role of total calorie intake in sustained weight loss

• Potential risks: micronutrient deficiency, lipid changes, sustainability concerns

• When lipid profile and HbA1c monitoring are recommended

• Situations where restrictive diet plans may be discouraged pending medical assessment

We explain how doctors assess BMI trends, waist circumference, blood pressure, lipid profile, HbA1c, kidney function, and overall cardiovascular risk during an online consultation in the EU. Long-term success depends on dietary adherence, nutritional adequacy, and sustainable lifestyle change rather than carbohydrate restriction alone.

This episode reflects the clinical standards used by Mobi Doctor, where metabolic consultations are reviewed by a registered physician in line with EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/how-do-low-carbohydrate-diets-affect-weight-in-the-long-run

Can a novel experimental test help diagnose Parkinson’s disease earlier, and what does the evidence show in Europe?

Parkinson’s disease early diagnosis explained: alpha-synuclein biomarkers, experimental assays, neurological assessment, and clinical validation standards.

In this episode, we review emerging research on new diagnostic tests that aim to detect Parkinson’s disease before advanced motor symptoms appear.

You’ll learn:

• What Parkinson’s disease is (a progressive neurodegenerative disorder)

• The role of alpha-synuclein protein aggregation

• How experimental biomarker tests may detect abnormal protein changes

• The difference between research tools and approved clinical diagnostics

• Why neurological examination remains central to diagnosis

• Early symptoms such as tremor, rigidity, slowed movement, and non-motor changes

• Why experimental tests are not yet routine in EU clinical practice

We explain how doctors assess motor signs, family history, medication response, imaging results, and differential diagnoses during a neurological evaluation in the EU. Experimental biomarker tests require further validation before widespread clinical adoption.

This episode reflects the clinical standards used by Mobi Doctor, where neurological concerns are reviewed by a registered physician in line with EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/novel-experimental-test-may-aid-early-diagnosis-of-parkinsons-disease

What are the best diets for overall health in 2024, and why are the Mediterranean, DASH, and MIND diets recommended in Europe?

Mediterranean vs DASH vs MIND diet explained: cardiovascular risk reduction, blood pressure control, cognitive health, and evidence-based nutrition.

In this episode, we review why these dietary patterns consistently rank highest for overall health under EU medical guidance.

You’ll learn:

• How the Mediterranean diet emphasises olive oil, vegetables, legumes, fish, and whole grains

• Why the DASH diet is designed to lower blood pressure through reduced sodium and balanced nutrients

• How the MIND diet combines Mediterranean and DASH principles for brain health

• Evidence linking these diets to reduced cardiovascular disease risk

• The role of fibre, unsaturated fats, and antioxidant intake

• Why sustainable dietary patterns outperform short-term restrictive plans

• When metabolic screening (lipids, HbA1c, blood pressure) is recommended

We explain how doctors assess BMI, waist circumference, blood pressure, lipid profile, glucose levels, kidney function, and existing conditions during an online consultation in the EU. Long-term adherence and nutritional adequacy are central to health outcomes.

This episode reflects the clinical standards used by Mobi Doctor, where metabolic and cardiovascular consultations are reviewed by a registered physician in line with EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/best-diets-2024-mediterranean-diet-dash-diet-and-mind-diets-best-for-overall-health

Are Ozempic, Wegovy, and other GLP-1 receptor agonists linked to pancreatic cancer risk, and what does current evidence show in Europe?

GLP-1 receptor agonists and pancreatic cancer explained: semaglutide, liraglutide, tirzepatide, safety data, observational studies, and regulatory review.

In this episode, we review recent research evaluating whether GLP-1RA medications are associated with increased pancreatic cancer risk and how doctors interpret these findings under EU medical guidance.

You’ll learn:

• What GLP-1 receptor agonists are and how they work in diabetes and weight management

• Why earlier safety concerns emerged regarding pancreatitis and pancreatic cancer

• What recent large-scale studies report about cancer risk

• The difference between association, signal detection, and proven causation

• Known side effects, including gastrointestinal symptoms

• When pancreatic symptoms (persistent upper abdominal pain, jaundice, unexplained weight loss) require urgent evaluation

• Situations where treatment initiation or continuation may be declined pending medical review

We explain how doctors assess BMI, HbA1c, family history of pancreatic disease, pancreatitis history, liver function, and overall cancer risk factors during an online consultation in the EU. Current evidence does not demonstrate a confirmed increased pancreatic cancer risk, but ongoing monitoring remains standard practice.

This episode reflects the clinical standards used by Mobi Doctor, where metabolic consultations are reviewed by a registered physician in line with EU prescribing guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/ozempic-wegovy-other-glp-1ra-drugs-not-linked-to-increased-pancreatic-cancer-risk-study-finds

What is the link between diarrhoea and irritable bowel syndrome (IBS), and how can symptoms be eased safely in Europe?

IBS with diarrhoea explained: functional bowel disorder, gut motility changes, stress triggers, diet modification, and red flag criteria.

In this episode, we outline how IBS-D (IBS with diarrhoea) is diagnosed and managed under EU medical guidance.

You’ll learn:

• What defines IBS (recurrent abdominal pain with altered bowel habits)

• How IBS-D differs from infection or inflammatory bowel disease (IBD)

• The role of the gut–brain axis and stress

• How low-FODMAP dietary adjustment may reduce symptoms

• When loperamide or antispasmodics may be considered

• The importance of fibre type (soluble vs insoluble)

• Red flag symptoms such as weight loss, blood in stool, nocturnal diarrhoea, or anaemia

• Situations where medication requests may be declined pending further investigation

We explain how doctors assess symptom duration (Rome IV criteria), stool pattern, dietary triggers, family history, inflammatory markers, and recent travel during an online consultation in the EU. IBS is a diagnosis of exclusion, and other causes must be ruled out before confirmation.

This episode reflects the clinical standards used by Mobi Doctor, where gastrointestinal consultations are reviewed by a registered physician in line with EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/diarrhea-and-ibs-and-how-to-ease-symptoms

What’s the connection between IBS and restless leg syndrome, and what does research show in Europe?

IBS and restless leg syndrome explained: gut–brain axis, iron deficiency, dopamine pathways, sleep disruption, and clinical overlap.

In this episode, we review studies suggesting a possible association between irritable bowel syndrome (IBS) and restless leg syndrome (RLS), and how doctors interpret these findings under EU medical guidance.

You’ll learn:

• What IBS is (a functional bowel disorder with abdominal pain and altered stool pattern)

• What RLS is (an urge to move the legs, often worse at night)

• How the gut–brain axis may link digestive and neurological symptoms

• The role of iron deficiency in RLS

• Why sleep disturbance can worsen both conditions

• The difference between association and proven causation

• When blood tests (iron studies, ferritin) may be indicated

• Red flag symptoms requiring specialist referral

We explain how doctors assess bowel symptoms, sleep quality, neurological signs, ferritin levels, medication use, and mental health factors during an online consultation in the EU. Overlapping symptoms require careful evaluation to exclude anaemia, neuropathy, or inflammatory disease.

This episode reflects the clinical standards used by Mobi Doctor, where gastrointestinal and neurological concerns are reviewed by a registered physician in line with EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/whats-the-connection-between-ibs-and-restless-leg-syndrome

Is migraine linked to an increased risk of inflammatory bowel disease (IBD), and what does the evidence show in Europe?

Migraine and IBD explained: inflammatory pathways, gut–brain axis, autoimmune mechanisms, observational data, and clinical interpretation.

In this episode, we review new research suggesting an association between migraine and inflammatory bowel disease, and how doctors interpret these findings under EU medical guidance.

You’ll learn:

• What migraine is (a neurological disorder with recurrent headache and sensory symptoms)

• What IBD includes (Crohn’s disease and ulcerative colitis)

• How systemic inflammation may play a role in both conditions

• The difference between correlation and proven causation

• Why shared genetic or immune factors are being studied

• When gastrointestinal symptoms warrant further investigation

• Red flag signs such as persistent diarrhoea, blood in stool, weight loss, or severe abdominal pain

We explain how doctors assess headache pattern, gastrointestinal symptoms, inflammatory markers, medication use, and family history during an online consultation in the EU. An association in research does not mean migraine directly causes IBD, and individual risk depends on overall clinical context.

This episode reflects the clinical standards used by Mobi Doctor, where neurological and gastrointestinal consultations are reviewed by a registered physician in line with EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/migraine-linked-to-increased-risk-of-ibd-in-new-study

How can chronic inflammation in psoriasis be managed, and when is medical treatment required in Europe?

Psoriasis and chronic inflammation explained: autoimmune skin disease, systemic inflammation, plaque psoriasis, biologic therapy, and monitoring criteria.

In this episode, we outline how psoriasis is more than a skin condition and how doctors manage inflammatory burden under EU medical guidance.

You’ll learn:

• What psoriasis is (an immune-mediated inflammatory disorder)

• Why chronic inflammation can extend beyond the skin

• Common triggers: stress, infection, skin injury, certain medications

• Topical treatments (corticosteroids, vitamin D analogues)

• When phototherapy or systemic treatments are considered

• The role of biologic therapies in moderate to severe cases

• Links between psoriasis and cardiovascular risk

• Situations where treatment escalation may require specialist referral

We explain how doctors assess plaque distribution, severity (PASI considerations), joint symptoms (psoriatic arthritis), cardiovascular risk factors, and treatment response during an online consultation in the EU. Moderate to severe psoriasis often requires coordinated dermatology follow-up.

This episode reflects the clinical standards used by Mobi Doctor, where dermatology consultations are reviewed by a registered physician in line with EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/managing-chronic-inflammation-with-psoriasis

Does nutrition affect Alzheimer’s disease progression, and what does current evidence show in Europe?

Alzheimer’s disease and nutrition explained: neurodegeneration, Mediterranean diet, MIND diet, omega-3 fatty acids, vascular risk factors, and clinical interpretation.

In this episode, we examine research on whether dietary patterns influence cognitive decline and how doctors interpret these findings under EU medical guidance.

You’ll learn:

• What Alzheimer’s disease is (a progressive neurodegenerative condition)

• How inflammation, oxidative stress, and vascular health affect the brain

• Evidence supporting Mediterranean and MIND dietary patterns

• The role of omega-3 fatty acids, polyphenols, and whole grains

• Why managing hypertension and diabetes is critical for brain health

• The limits of single-nutrient supplements in slowing progression

• When weight loss or malnutrition in dementia requires medical review

We explain how doctors assess BMI, unintended weight loss, vitamin B12 levels, thyroid function, cardiovascular risk factors, medication profile, and overall dietary intake during an online consultation in the EU. Nutrition supports general health and vascular risk reduction, but it is not a standalone treatment for Alzheimer’s disease.

This episode reflects the clinical standards used by Mobi Doctor, where neurological and metabolic consultations are reviewed by a registered physician in line with EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/does-nutrition-affect-alzheimers-disease-progression-insights-and-research

Can diet and exercise reverse prediabetes, and what does the evidence show in Europe?

Prediabetes reversal explained: impaired fasting glucose, HbA1c range, insulin resistance, weight reduction, and lifestyle intervention outcomes.

In this episode, we examine whether structured diet and physical activity can return blood glucose levels to the non-diabetic range under EU medical guidance.

You’ll learn:

• What defines prediabetes (HbA1c 5.7–6.4% / 39–47 mmol/mol)

• How insulin resistance develops

• Evidence from lifestyle intervention trials

• The role of weight loss (5–10%) in improving glycaemic control

• Why resistance training improves glucose uptake

• When metformin may be considered

• Red flag signs of progression to type 2 diabetes

• Situations where medication requests may be declined pending lifestyle trial

We explain how doctors assess HbA1c trends, fasting glucose, BMI, waist circumference, blood pressure, lipid profile, family history, and physical activity levels during an online consultation in the EU. Prediabetes can often be improved with sustained lifestyle change, but monitoring is essential to prevent progression.

This episode reflects the clinical standards used by Mobi Doctor, where metabolic consultations are reviewed by a registered physician in line with EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/can-diet-and-exercise-reverse-prediabetes